Clinical Trials Directory

Trials / Conditions / Necrotizing Soft Tissue Infection

Necrotizing Soft Tissue Infection

18 registered clinical trials studyying Necrotizing Soft Tissue Infection6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAdjunctive Hyperbaric Oxygen Treatment for Patients With Necrotizing Soft-Tissue Infection (HOT-NSTI Trial).
NCT07489274
Ole HyldegaardPhase 4
Enrolling By InvitationNecrotizing Soft Tissue Infections
NCT07107555
European Society for Trauma and Emergency Surgery
RecruitingThe Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
NCT06857708
Benjamin T. MillerN/A
CompletedMicroMatrix® Flex in Tunneling Wounds
NCT06629506
Integra LifeSciences CorporationN/A
RecruitingThe Role of Circadian Clock Proteins in Innate and Adaptive Immunity
NCT03482245
Washington University School of MedicineN/A
RecruitingShorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
NCT06002607
University of California, Irvine
UnknownAdjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infe
NCT06126263
National Institutes of Health Clinical Center (CC)
RecruitingMyriad™ Augmented Soft Tissue Reconstruction Registry
NCT05243966
Aroa Biosurgery Limited
UnknownSKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort St
NCT05116956
Henri Mondor University Hospital
TerminatedHAT for the Treatment of Sepsis Associated With NASTI
NCT05157360
Ascension HealthPhase 1 / Phase 2
UnknownCharacteristics of Patients With Necrotizing Soft Tissue Infections
NCT04801615
Aarhus University Hospital
TerminatedTo Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections
NCT05032625
New York Medical College
TerminatedPhase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury
NCT03403751
Atox Bio LtdPhase 3
CompletedImmunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
NCT02111161
Anders PernerPhase 2
WithdrawnNegative Pressure Wound Therapy and Allogeneic Human Skin Grafts for Wound Bed Preparation
NCT02314468
University Hospital, GhentN/A
CompletedPrognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
NCT03147352
Ole Hyldegaard
CompletedBiomarkers in Patients With Flesh-eating Bacterial Infections
NCT02180906
Ole Hyldegaard
CompletedModulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treat
NCT02501382
Ole Hyldegaard